Nu Holdings Q3 Preview Does Not Change WAIT Stance Ahead of Report

What happened

Nu Holdings is set to report third-quarter 2026 results after the market close on November 12, and the preview article offers no new operating data beyond the reporting date. The latest DeepValue master report, prepared before the Q3 print, rates the stock WAIT at $14 with a 4.0 conviction, citing rising capital intensity and reserve drag that offset 42% revenue growth in Q1 2026. Key stress points include Brazil CET1 falling to 11.3% from 13.0%, risk-adjusted NIM slipping to 9.5% from 10.5%, and NPL 15-90 climbing to 5.0% from 4.1% while managerial cost of credit nearly doubled to $1.79 billion. The report frames the Mexico bank authorization in July 2026 as a catalyst that could lift deposits and revenue but also adds credit and capital risk, with near-term checkpoints on CET1 stability and delinquency normalization. Because the article itself adds no new information, the WAIT stance stands, and investors should focus on whether Q3 results confirm stabilization in Brazil capital ratios and credit quality.

Implication

Q3 results will be the first test after Mexico's bank launch and should show whether deposit migration and loan growth are accretive without further deterioration in early delinquencies. The DeepValue report sets a trim above $17 and an attractive entry at $12, with a base case implied value of $15, so current prices near $14 offer limited safety. Investors should monitor three metrics in the report: Brazil CET1 relative to 11.3%, consolidated NPL 15-90 relative to 5.0%, and risk-adjusted NIM relative to 9.5%; any deterioration beyond Q1 levels would push the thesis toward the bear case of $11. Conversely, clear stabilization on all three and Mexico break-even or better would support revisiting the bull case of $18. Until those numbers print, the stock merits a wait rather than fresh capital, especially given management's tendency to frame reserve builds as non-deteriorating without complete Mexico-specific credit disclosures.

Thesis delta

No shift in the core WAIT thesis; the earnings preview merely confirms the reporting date and adds no independent data. The DeepValue report's guardrails remain unchanged: buy only near $12 with evidence CET1 holds above 11.3%, risk-adjusted NIM recovers above 9.5%, and NPL 15-90 does not rise further. Failure to meet these levels in Q3 would strengthen the bear case and justify trimming even at current levels.